Annovis BioAdvance News Portfolio News

Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging

By WebmasterApril 28, 2022November 1st, 2024No Comments

Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging

Collaboration to Develop Pharmacodynamic Biomarkers for Buntanetap

Previous PostRelmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Frontiers in Pharmacology
Next PostScripps Health and UT Health San Antonio purchase Oncora's software to improve physician documentation and enhance personalized cancer care